217 related articles for article (PubMed ID: 30818760)
1. Cell Metabolism Control Through O-GlcNAcylation of STAT5: A Full or Empty Fuel Tank Makes a Big Difference for Cancer Cell Growth and Survival.
Rauth M; Freund P; Orlova A; Grünert S; Tasic N; Han X; Ruan HB; Neubauer HA; Moriggl R
Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30818760
[TBL] [Abstract][Full Text] [Related]
2. O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies.
Freund P; Kerenyi MA; Hager M; Wagner T; Wingelhofer B; Pham HTT; Elabd M; Han X; Valent P; Gouilleux F; Sexl V; Krämer OH; Groner B; Moriggl R
Leukemia; 2017 Oct; 31(10):2132-2142. PubMed ID: 28074064
[TBL] [Abstract][Full Text] [Related]
3. Essential role of O-GlcNAcylation in stabilization of oncogenic factors.
Makwana V; Ryan P; Patel B; Dukie SA; Rudrawar S
Biochim Biophys Acta Gen Subj; 2019 Aug; 1863(8):1302-1317. PubMed ID: 31034911
[TBL] [Abstract][Full Text] [Related]
4. EGF promotes PKM2 O-GlcNAcylation by stimulating O-GlcNAc transferase phosphorylation at Y976 and their subsequent association.
Wang Y; Shu H; Liu J; Jin X; Wang L; Qu Y; Xia M; Peng P; Feng Y; Wei M
J Biol Chem; 2022 Sep; 298(9):102340. PubMed ID: 35931120
[TBL] [Abstract][Full Text] [Related]
5. O-GlcNAc elevation through activation of the hexosamine biosynthetic pathway enhances cancer cell chemoresistance.
Liu Y; Cao Y; Pan X; Shi M; Wu Q; Huang T; Jiang H; Li W; Zhang J
Cell Death Dis; 2018 May; 9(5):485. PubMed ID: 29706631
[TBL] [Abstract][Full Text] [Related]
6. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.
Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436
[TBL] [Abstract][Full Text] [Related]
7. Bittersweet tumor development and progression: Emerging roles of epithelial plasticity glycosylations.
Phillips RM; Lam C; Wang H; Tran PT
Adv Cancer Res; 2019; 142():23-62. PubMed ID: 30885363
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways.
Nagy ZS; Wang Y; Erwin-Cohen RA; Aradi J; Monia B; Wang LH; Stepkowski SM; Rui H; Kirken RA
J Leukoc Biol; 2002 Oct; 72(4):819-28. PubMed ID: 12377952
[TBL] [Abstract][Full Text] [Related]
9. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
Kirken RA; Erwin RA; Wang L; Wang Y; Rui H; Farrar WL
J Immunol; 2000 Nov; 165(9):5097-104. PubMed ID: 11046040
[TBL] [Abstract][Full Text] [Related]
10. O-GlcNAc in cancer biology.
Ma Z; Vosseller K
Amino Acids; 2013 Oct; 45(4):719-33. PubMed ID: 23836420
[TBL] [Abstract][Full Text] [Related]
11. STAT3 and STAT5 Signaling Thresholds Determine Distinct Regulation for Innate Receptor-Induced Inflammatory Cytokines, and
Hedl M; Sun R; Huang C; Abraham C
J Immunol; 2019 Dec; 203(12):3325-3338. PubMed ID: 31732533
[TBL] [Abstract][Full Text] [Related]
12. The complex roles of STAT3 and STAT5 in maintaining redox balance: Lessons from STAT-mediated xCT expression in cancer cells.
Linher-Melville K; Singh G
Mol Cell Endocrinol; 2017 Aug; 451():40-52. PubMed ID: 28202313
[TBL] [Abstract][Full Text] [Related]
13. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional activation of signal transducer and activator of transcription (STAT) 3 and STAT5B partially mediate homeobox A1-stimulated oncogenic transformation of the immortalized human mammary epithelial cell.
Mohankumar KM; Perry JK; Kannan N; Kohno K; Gluckman PD; Emerald BS; Lobie PE
Endocrinology; 2008 May; 149(5):2219-29. PubMed ID: 18276758
[TBL] [Abstract][Full Text] [Related]
15. Serine phosphorylation of the Stat5a C-terminus is a driving force for transformation.
Friedbichler K; Hoelbl A; Li G; Bunting KD; Sexl V; Gouilleux F; Moriggl R
Front Biosci (Landmark Ed); 2011 Jun; 16(8):3043-56. PubMed ID: 21622220
[TBL] [Abstract][Full Text] [Related]
16. Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro.
Zhang N; Chen X
Biotechnol Appl Biochem; 2016 Nov; 63(6):841-851. PubMed ID: 26333304
[TBL] [Abstract][Full Text] [Related]
17. Cancer metabolism and elevated O-GlcNAc in oncogenic signaling.
Ma Z; Vosseller K
J Biol Chem; 2014 Dec; 289(50):34457-65. PubMed ID: 25336642
[TBL] [Abstract][Full Text] [Related]
18. Serine phosphorylation of GH-activated signal transducer and activator of transcription 5a (STAT5a) and STAT5b: impact on STAT5 transcriptional activity.
Park SH; Yamashita H; Rui H; Waxman DJ
Mol Endocrinol; 2001 Dec; 15(12):2157-71. PubMed ID: 11731617
[TBL] [Abstract][Full Text] [Related]
19. O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle.
Hanover JA; Chen W; Bond MR
J Bioenerg Biomembr; 2018 Jun; 50(3):155-173. PubMed ID: 29594839
[TBL] [Abstract][Full Text] [Related]
20. O-GlcNAcylation in Cancer Biology: Linking Metabolism and Signaling.
Ferrer CM; Sodi VL; Reginato MJ
J Mol Biol; 2016 Aug; 428(16):3282-3294. PubMed ID: 27343361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
